S&P 500   3,784.71 (-0.29%)
DOW   30,889.07 (-0.33%)
QQQ   314.86 (+0.16%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,784.71 (-0.29%)
DOW   30,889.07 (-0.33%)
QQQ   314.86 (+0.16%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,784.71 (-0.29%)
DOW   30,889.07 (-0.33%)
QQQ   314.86 (+0.16%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,784.71 (-0.29%)
DOW   30,889.07 (-0.33%)
QQQ   314.86 (+0.16%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
Log in
OTCMKTS:BIEI

Premier Biomedical Short Interest Ratio and Short Volume

$0.0015
0.00 (0.00 %)
(As of 01/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.01
Volume42.82 million shs
Average Volume69.91 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Short Interest

Premier Biomedical (OTCMKTS:BIEI) Short Interest Data

Current Short Volume:367,200 shares
Previous Short Volume:7,300 shares
Change Vs. Previous Month:+4,930.14%
Dollar Volume Sold Short:$0.00
Short Interest Ratio / Days to Cover:0.0
Last Record Date:December, 31 2020
Short Percent of Float:0.00%
Today's Trading Volume:42,820,326 shares
Average Trading Volume:69,910,484 shares
Today's Volume Vs. Average:-38.75%



Premier Biomedical (OTCMKTS:BIEI) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
12/31/2020367,200 $0.00 4,930.1%0.0%0$0.00
12/15/2020367,200 $0.00 4,930.1%0.0%0$0.00
11/30/20207,300 $0.00 0.0%0.0%0$0.00
10/15/202040,300 $0.00 122.7%0.0%0$0.00
9/30/202018,100 $0.00 0.0%0.0%0$0.00
8/31/202063,700 $0.00 2.9%0.0%0$0.00
8/14/202061,900 $0.00 -40.6%0.0%0$0.00
7/31/2020104,200 $0.00 0.0%0.0%0$0.00
5/15/202059,700 $0.00 0.0%0.0%0$0.00
4/15/202077,100 $0.00 4.9%0.0%0$0.00
3/31/202073,500 $0.00 635.0%0.0%0$0.00
3/13/202010,000 $0.00 0.0%0.0%0$0.00
1/31/2020210,000 $0.00 607.1%0.0%0$0.00
1/15/202029,700 $0.00 0.0%0.0%0$0.00

Premier Biomedical (OTCMKTS:BIEI) Short Interest FAQ

speech bubbles
speech bubbles











What is Premier Biomedical's current short interest?

Short interest is the volume of Premier Biomedical shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 367,200 shares of BIEI short. 0.00% of Premier Biomedical's shares are currently sold short. View details.

Is Premier Biomedical's short interest increasing or decreasing?

Premier Biomedical saw a increase in short interest in December. As of December 31st, there was short interest totaling 367,200 shares, an increase of 4,930.1% from the previous total of 7,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Premier Biomedical's short interest compare to its competitors?

0.00% of Premier Biomedical's shares are currently sold short. Here is how the short interest of companies in the industry of "drug manufacturers - specialty & generic" compare to Premier Biomedical: Applied Biosciences Corp. (0.00%), Cansortium Inc. (0.00%), Charlotte's Web Holdings, Inc. (0.00%), Choom Holdings Inc. (0.00%), Cipher Pharmaceuticals Inc. (0.00%), CLS Holdings USA, Inc. (0.00%), Cosmos Holdings Inc. (0.00%), Cresco Labs Inc. (0.00%), Curaleaf Holdings, Inc. (0.00%), and Elixinol Global Limited (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

What does it mean to sell short Premier Biomedical stock?

Short selling BIEI is an investing strategy that aims to generate trading profit from Premier Biomedical as its price is falling. To short Premier Biomedical stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Premier Biomedical will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Premier Biomedical?

A short squeeze for Premier Biomedical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIEI, which in turn drives the price of the stock up even further.

How often is Premier Biomedical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIEI, twice per month. The most recent reporting period available is December, 31 2020.


This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.